RAPT Therapeutics, Inc. - stock earnings
RAPT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -30.9 million USD | ? USD |
| 2023Q3 | -31.4 million USD | ? USD |
| 2023Q2 | -25.3 million USD | ? USD |
| 2023Q1 | -27.0 million USD | ? USD |
| 2022Q4 | -21.5 million USD | 641000 USD |
| 2022Q3 | -20.8 million USD | ? USD |
| 2022Q2 | -19.5 million USD | 886000 USD |
| 2022Q1 | -20.2 million USD | 641000 USD |
| 2021Q4 | -17.9 million USD | 756000 USD |
| 2021Q3 | -18.7 million USD | 966000 USD |
| 2021Q2 | -16.1 million USD | 869000 USD |
| 2021Q1 | -16.5 million USD | 1.2 million USD |
| 2020Q4 | -12.7 million USD | 1.3 million USD |
| 2020Q3 | -14.6 million USD | 1.5 million USD |
| 2020Q2 | -12.4 million USD | 1.3 million USD |
| 2020Q1 | -13.1 million USD | 935000 USD |
| 2019Q4 | -13.2 million USD | ? USD |
| 2019Q3 | -10.0 million USD | ? USD |
| 2019Q2 | -10.6 million USD | ? USD |
| 2019Q1 | -9.2 million USD | ? USD |
| 2018Q4 | -9.4 million USD | ? USD |
| 2018Q3 | -10.3 million USD | ? USD |
| 2018Q2 | -8.2 million USD | ? USD |
| 2018Q1 | -8.2 million USD | ? USD |
RAPT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -116.8 million USD | ? USD |
| 2022 | -81.9 million USD | 1.5 million USD |
| 2021 | -68.2 million USD | 3.8 million USD |
| 2020 | -52.9 million USD | 5.0 million USD |
| 2019 | -43.0 million USD | 935000 USD |
| 2018 | -36.1 million USD | ? USD |
| 2017 | -29.1 million USD | ? USD |
RAPT
Price: $8.18
52 week price:
Earnings Per Share: -3.05 USD
P/E Ratio: -9.06
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 309600
Market Capitalization: 278.7 million